A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer

NCT01588990 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Bevacizumab
DRUG: Leucovorin
DRUG: 5-Fluouracil
DRUG: Irinotecan

Sponsor

Hoffmann-La Roche